ÂÜÀòÂÒÂ×

Can Ongen has a strong background in leadership positions within the pharmaceutical and healthcare industry. Can previously served as the Chief Operating Officer at Teoxane Laboratories starting in 2023. Prior to that, from 2021 to 2023, they held the position of Chief Commercial Officer and Non-Executive Director. In this role, they were responsible for market and business development, strategic planning, distributor management, and building global commercial and marketing organizations. Before that, they worked at Galderma as the Vice President and Head of International Markets from 2017 to 2020, and as the Vice President and Head of EMEA & LATAM from 2014 to 2017. Earlier in their career, they held various leadership roles at Alcon, including Area Vice President for EMEA and Area Director for EMEA. Can Ongen began their career at Alcon in 1990, and their career there spanned until 2014.

Can Ongen's education history includes the following:

- From 2019 to 2020, Can Ongen attended INSEAD and pursued a degree in Corporate Governance with a focus on Board of Directorship.

- From 2020 to 2021, Can Ongen studied at EPFL (École polytechnique fédérale de Lausanne) in the field of Startup Board Academy, obtaining a degree in Board of Directors.

- In 2011, Can Ongen briefly attended Harvard Business School to specialize in Leadership in Pharmaceuticals & Biotech. The specific degree obtained is not mentioned.

- In 2016, Can Ongen completed a program at London Business School, focusing on Advanced Leadership. No specific degree is specified for this.

- In 2006 and 2007, Can Ongen participated in an Executive Management program at IMD.

- It is unknown when Can Ongen started and completed the MBA program at Istanbul University's Institute for Excellence in Business Education. No specific dates are provided in the given information.

- Can Ongen obtained a degree in Pharmacy from Marmara University, but the specific duration of this program is not mentioned.